BMS’ move for Karuna comes a few weeks after AbbVie agreed an $8.7 billion deal to acquire Cerevel Therapeutics, another company developing a schizophrenia drug with a novel mechanism of action.

Steve Paul has been appointed CEO of US biotech Karuna, to lead development of the psychiatric drug xanomeline.

Songs often have titles that aren't mentioned in their lyrics. This article examines how this trend has evolved and its impact on listeners.